About Oscar Health, Inc. Class A Common Stock (OSCR)
Oscar Health is a health insurance company that primarily utilizes technology to streamline the healthcare experience for its members. It offers individual and family health plans, as well as small group insurance options, focusing on providing affordable coverage and personalized care. Oscar leverages a user-friendly digital platform to enhance member engagement, facilitate telemedicine services, and simplify access to healthcare resources, aiming to improve health outcomes while reducing costs for consumers. Through its emphasis on innovative technology and customer service, Oscar seeks to redefine the health insurance landscape and empower its members with the tools and information they need to manage their health effectively. Read More
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data (“2Q Risk Adjustment Reports”) from Wakely, an independent actuarial firm, that analyzes paid claims submissions through April 30, 2025 for most Marketplace insurance carriers.
Global financial markets are poised at a critical juncture as a confluence of high-impact corporate earnings releases and key macroeconomic indicators is expected to shape the investment climate for the second half of the year. With major equity indices such as the S&P 500 hovering near record highs, investors
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 3.1% in the morning session after the stock continued a sharp decline from the previous session, which was fueled by multiple analyst downgrades and broader weakness in the healthcare plans sector.
Shares of health insurance company Oscar Health (NYSE:OSCR) fell 5% in the afternoon session after Wells Fargo downgraded the stock and slashed its price target. The financial institution lowered its rating on the health insurer to "Underweight" from "Equal Weight" and cut its price target to $10 from $16.
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how health insurance providers stocks fared in Q1, starting with Clover Health (NASDAQ:CLOV).
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and worst performers in the health insurance providers industry.
